Treatment of a humanised NPC mouse model with anti-CCL20 monoclonal antibody (mAb) resulted in a decrease in CD4+CD25+ regulatory T cells (Treg) recruitment (119). The gene discussed is CCL20; the disease is nasopharyngeal carcinoma.